Sequent Scientific Reports Significant Growth in Financial Performance and Operational Efficiency
Sequent Scientific, a small-cap company in the Pharmaceuticals & Biotechnology sector, recently experienced an evaluation adjustment due to strong financial performance. Key metrics, including profit before tax and profit after tax, showed significant growth, while technical indicators suggested a mildly bullish stock trend and increased institutional investor participation.
Sequent Scientific, a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently undergone an evaluation adjustment reflecting its financial performance and technical indicators. The company reported a very positive financial performance for the quarter ending March 2025, with significant growth metrics. Notably, profit before tax less other income (PBT LESS OI) reached Rs 14.99 crore, marking a growth of 347.46%. Additionally, profit after tax (PAT) soared to Rs 9.54 crore, showcasing an impressive growth rate of 608.6%. The return on capital employed (ROCE) stood at its highest level of 9.28%, while net sales hit a record Rs 401.70 crore. Other key indicators, such as operating profit to interest ratio and earnings per share, also reached new highs, indicating robust operational efficiency.
On the technical front, the stock's trend has shifted to a mildly bullish stance, supported by positive signals from various technical indicators, including MACD and Bollinger Bands. Institutional investors have shown increased participation, raising their stake in the company, which reflects a growing confidence in its fundamentals.
For more insights on Sequent Scientific's performance, you can Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
